Abstract
7586 Background: Amrubicin (AMR), a totally synthetic 9-aminoanthracycline and potent topoisomerase II inhibitor, is approved in Japan for the treatment of lung cancer. We investigate the recommend...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
